Esperion Therapeutics (ESPR) stock forecast for 2026. Forecast tables and graphs.







Maximizing Profits: When is the Right Time to Sell Your Business?

April 23, 2024 Maximizing Profits: When is the Right Time to Sell Your Business?

Selling a business can be a momentous decision filled with many considerations and uncertainties. As an entrepreneur, this also symbolizes your years of…
Improve Your Financial Status: A How-To Guide

April 12, 2024 Improve Your Financial Status: A How-To Guide

Navigating through the complexities of personal finance can often feel like walking through a maze blindfolded. This guide is crafted especially for you,…
How ZIM Integrated Container Tracking is Revolutionizing Global Trade

April 12, 2024 How ZIM Integrated Container Tracking is Revolutionizing Global Trade

Have you ever wondered how your online shopping packages get to you? A big part of the answer is ZIM Integrated Container Tracking.…
6 Best Growth Stocks To Buy Now According to Metatrader 5

March 15, 2024 6 Best Growth Stocks To Buy Now According to Metatrader 5

One of the reasons investors prefer growth stocks is that they are expected to perform better than other companies in terms of sales…

Esperion Therapeutics (ESPR) stock forecast for 2026

Updated: May 26, 2024 (16:06)

Sector: Healthcare

The share price of Esperion Therapeutics, Inc. (ESPR) now

What analysts predict: $7.41
52-week High/Low: $3.4 / $0.7

50/200 Day Moving Average: $2.303 / $1.855

This figure corresponds to the Average Price over the previous 50/200 days. For Esperion Therapeutics stocks, the 50-day moving average is the resistance level today.

For Esperion Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Esperion Therapeutics, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Esperion Therapeutics stock price in 2026. How much will one Esperion Therapeutics share be worth in 2026? Is it worth taking profit / loss on ESPR stock now or waiting? What are analysts' forecasts for Esperion Therapeutics stock?

We forecast Esperion Therapeutics stock performance using neural networks based on historical data on ESPR stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Esperion Therapeutics, Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Esperion Therapeutics analysts is $7.41. Today 200 Day Moving Average is the support level (1.855 $). 50 Day Moving Average is the resistance level (2.303 $).




Historical and forecast chart of Esperion Therapeutics, Inc. stock

The chart below shows the historical price of Esperion Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the ESPR stock price can be found in the table below.


Esperion Therapeutics is a publicly available US pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated LDL-C levels.

Esperion Therapeutics (ESPR) Forecast for 2026

Month Target Pes. Opt. Vol., %
Jan 1.65 1.32 1.98 32.97 %
Feb 1.46 1.22 1.61 24.23 %
Mar 1.50 1.21 1.61 24.35 %
Apr 1.66 1.53 2.05 25.28 %
May 2.10 1.93 2.24 14.07 %
Jun 2.30 1.93 2.75 29.62 %
Jul 2.53 2.06 3.00 31.37 %
Aug 2.40 2.09 2.95 29.32 %
Sep 1.81 1.49 2.11 29.61 %
Oct 1.89 1.49 2.01 25.75 %
Nov 2.04 1.77 2.47 28.09 %
Dec 1.59 1.44 1.83 21.39 %

Esperion Therapeutics information and performance

Esperion Therapeutics Address

3891 RANCHERO DRIVE, SUITE 150, ANN ARBOR, MI, US

Market Capitalization: 403 550 000 $

Market capitalization of the Esperion Therapeutics, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of ESPR shares in the company outstanding by the market price of one share.

EBITDA: -34 565 000 $

EBITDA of Esperion Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: -4.78

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -0.9

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 4.661
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: 1.028

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.985

Enterprise Value (EV) /Revenue

EV To EBITDA: -3.863

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 189460000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Esperion Therapeutics price target for 2026 by month


Target values for the price of one Esperion Therapeutics share for Jan 2026.

The weighted average target price per Esperion Therapeutics share in Jan 2026 is: 1.65.
In Jan, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 32.973% volatility is expected.
Pessimistic target level: 1.32
Optimistic target level: 1.98

Target values for the price of one Esperion Therapeutics share for Feb 2026.

The weighted average target price per Esperion Therapeutics share in Feb 2026 is: 1.46.
In Feb, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 24.229% volatility is expected.
Pessimistic target level: 1.22
Optimistic target level: 1.61

Target values for the price of one Esperion Therapeutics share for Mar 2026.

The weighted average target price per Esperion Therapeutics share in Mar 2026 is: 1.50.
In Mar, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 24.347% volatility is expected.
Pessimistic target level: 1.21
Optimistic target level: 1.61

Target values for the price of one Esperion Therapeutics share for Apr 2026.

The weighted average target price per Esperion Therapeutics share in Apr 2026 is: 1.66.
In Apr, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 25.284% volatility is expected.
Pessimistic target level: 1.53
Optimistic target level: 2.05

Target values for the price of one Esperion Therapeutics share for May 2026.

The weighted average target price per Esperion Therapeutics share in May 2026 is: 2.10.
In May, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 14.071% volatility is expected.
Pessimistic target level: 1.93
Optimistic target level: 2.24

Target values for the price of one Esperion Therapeutics share for Jun 2026.

The weighted average target price per Esperion Therapeutics share in Jun 2026 is: 2.30.
In Jun, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 29.624% volatility is expected.
Pessimistic target level: 1.93
Optimistic target level: 2.75

Target values for the price of one Esperion Therapeutics share for Jul 2026.

The weighted average target price per Esperion Therapeutics share in Jul 2026 is: 2.53.
In Jul, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 31.366% volatility is expected.
Pessimistic target level: 2.06
Optimistic target level: 3.00

Target values for the price of one Esperion Therapeutics share for Aug 2026.

The weighted average target price per Esperion Therapeutics share in Aug 2026 is: 2.40.
In Aug, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 29.316% volatility is expected.
Pessimistic target level: 2.09
Optimistic target level: 2.95

Target values for the price of one Esperion Therapeutics share for Sep 2026.

The weighted average target price per Esperion Therapeutics share in Sep 2026 is: 1.81.
In Sep, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 29.614% volatility is expected.
Pessimistic target level: 1.49
Optimistic target level: 2.11

Target values for the price of one Esperion Therapeutics share for Oct 2026.

The weighted average target price per Esperion Therapeutics share in Oct 2026 is: 1.89.
In Oct, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 25.755% volatility is expected.
Pessimistic target level: 1.49
Optimistic target level: 2.01

Target values for the price of one Esperion Therapeutics share for Nov 2026.

The weighted average target price per Esperion Therapeutics share in Nov 2026 is: 2.04.
In Nov, the Positive dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 28.086% volatility is expected.
Pessimistic target level: 1.77
Optimistic target level: 2.47

Target values for the price of one Esperion Therapeutics share for Dec 2026.

The weighted average target price per Esperion Therapeutics share in Dec 2026 is: 1.59.
In Dec, the Negative dynamics for Esperion Therapeutics, Inc. shares will prevail with possible monthly volatility of 21.391% volatility is expected.
Pessimistic target level: 1.44
Optimistic target level: 1.83



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.